Drug Information

Drug General Information
Drug ID
D0G5CS
Former ID
DNC011119
Drug Name
PINOCEMBRIN
Drug Type
Small molecular drug
Indication Discovery agent Phase 2 [524643]
Structure
Download
2D MOL

3D MOL
Formula
C15H12O4
Canonical SMILES
C1C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC=CC=C3
InChI
1S/C15H12O4/c16-10-6-11(17)15-12(18)8-13(19-14(15)7-10)9-4-2-1-3-5-9/h1-7,13,16-17H,8H2/t13-/m0/s1
InChIKey
URFCJEUYXNAHFI-ZDUSSCGKSA-N
PubChem Compound ID
68071
Target and Pathway
Target(s) Cytochrome P450 1B1 Target Info Inhibitor [531094]
BioCyc Pathway Superpathway of tryptophan utilization
Superpathway of melatonin degradation
Melatonin degradation I
KEGG Pathway Steroid hormone biosynthesis
Tryptophan metabolism
Metabolism of xenobiotics by cytochrome P450
Ovarian steroidogenesis
Chemical carcinogenesis
MicroRNAs in cancer
NetPath Pathway TSH Signaling Pathway
IL4 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
Reactome Endogenous sterols
WikiPathways Metapathway biotransformation
Estrogen metabolism
Benzo(a)pyrene metabolism
Tamoxifen metabolism
Tryptophan metabolism
Oxidation by Cytochrome P450
Nuclear Receptors Meta-Pathway
Estrogen Receptor Pathway
Sulindac Metabolic Pathway
Arylhydrocarbon receptor (AhR) signaling pathway
miR-targeted genes in muscle cell - TarBase
miR-targeted genes in lymphocytes - TarBase
miR-targeted genes in epithelium - TarBase
miR-targeted genes in adipocytes - TarBase
Phase 1 - Functionalization of compounds
References
Ref 524643ClinicalTrials.gov (NCT02059785) Phase ???tudy of Pinocembrin Injection to Treat Ischemic Stroke. U.S. National Institutes of Health.
Ref 531094Bioorg Med Chem. 2010 Sep 1;18(17):6310-5. Epub 2010 Jul 13.Selective inhibition of methoxyflavonoids on human CYP1B1 activity.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.